You have 9 free searches left this month | for more free features.

glutamate

Showing 1 - 25 of 1,293

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depression Trial in Atlanta (Infliximab, Placebo)

Active, not recruiting
  • Depression
  • Atlanta, Georgia
    Emory University
Jan 23, 2023

Glioblastoma Trial (Gabapentin, Sulfasalazine, Memantine)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Dec 15, 2022

Schwannomas, Malignant Tumors Trial in Baltimore (18F-DCFPyL Injection)

Completed
  • Schwannomas
  • Malignant Tumors
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    Johns Hopkins University
Jan 9, 2023

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Recruiting
  • Brain Tumor, Primary
  • Blood, CSF and tumor samples
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Mar 16, 2023

Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())

Recruiting
  • Treatment Resistant Depression
  • +2 more
  • Ketamine Hydrochloride
  • No intervention (placebo)
  • Oxford, United Kingdom
    Department of Psychiatry, University of Oxford
Mar 28, 2023

Cannabis Use Disorder Trial in New Haven ([18F]FPEB with PET, Cannabis abstinence)

Not yet recruiting
  • Cannabis Use Disorder
  • [18F]FPEB with PET
  • Cannabis abstinence
  • New Haven, Connecticut
    The Anlyan Center
Dec 22, 2022

Healthy Nutrition, Culinary Medicine, Sodium Excess Trial (MSG, NaCl (sodium chloride/table salt), KCl (potassium chloride/salt

Not yet recruiting
  • Healthy Nutrition
  • +2 more
  • MSG
  • +2 more
  • (no location specified)
Oct 21, 2022

Epilepsy in Children, Epilepsy in Youth, Randomized Controlled Trial Trial in Washington (Low Glutamate diet)

Completed
  • Epilepsy in Children
  • +4 more
  • Low Glutamate diet
  • Washington, District of Columbia
    American University
Jul 18, 2022

Psychosis Trial in Albuquerque (Lumateperone, Risperidone)

Recruiting
  • Psychosis
  • Albuquerque, New Mexico
    University of New Mexico
May 25, 2023

Normal Physiology Trial run by the National Institute of Mental Health (NIMH) (3T and 7T device)

Recruiting
  • Normal Physiology
  • 3T and 7T device
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

MDD, Treatment Resistant Depression, Bipolar Depression Trial in Rochester (Ketamine)

Enrolling by invitation
  • Major Depressive Disorder
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 12, 2022

Type1diabetes, Depressive Symptoms, MDD Trial (Glucose Clamp)

Completed
  • Type1diabetes
  • +2 more
  • Glucose Clamp
  • (no location specified)
Apr 29, 2022

Alcohol Drinking Trial in New Haven (Alcohol)

Recruiting
  • Alcohol Drinking
  • New Haven, Connecticut
    Yale University
Feb 7, 2022

Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction Trial in Karlskrona, Linköping, Örebro (Intravenous infusion

Completed
  • Coronary Artery Bypass
  • +3 more
  • Intravenous infusion of saline
  • Intravenous glutamate infusion
  • Karlskrona, Sweden
  • +2 more
May 21, 2022

Mapping Brain Glutamate in Humans: Sex Differences in Cigarette

Recruiting
  • Cigarette Smoking
  • +2 more
    • Los Angeles, California
      UCLA Semel Institute
    Mar 23, 2022

    Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

    Recruiting
    • Rotator Cuff Tendinitis
    • Chronic Pain
    • Kristiansund, Norway
      Department of Orthopedic Surgery, Kristiansund Hospital
    Mar 15, 2022

    Bipolar Disorder, Cannabis Use, Schizoaffective Disorder, Bipolar Type Trial in Charleston (Gabapentin, Placebo)

    Recruiting
    • Bipolar Disorder
    • +7 more
    • Charleston, South Carolina
      Medical University Of South Carolina
    Jul 6, 2022

    Clinical High Risk for Psychosis Trial in New York (Pomaglumetad methionil)

    Completed
    • Clinical High Risk for Psychosis
    • Pomaglumetad methionil
    • New York, New York
      New York State Psychiatric Institute
    Nov 5, 2021

    Cognitive Dysfunction Trial in West Haven (iomazenil)

    Completed
    • Cognitive Dysfunction
    • West Haven, Connecticut
      VHA Connecticut
    Jul 21, 2022

    Alcohol Withdrawal, Nutrition Disorders, Alcohol Use Disorder Trial (Riboflavin, Placebo)

    Not yet recruiting
    • Alcohol Withdrawal
    • +2 more
    • (no location specified)
    Sep 27, 2021

    Familial Alcoholism Vulnerability Trial in Hartford (Mavoglurant (AFQ056), Placebo)

    Completed
    • Familial Alcoholism Vulnerability
    • Mavoglurant (AFQ056)
    • Placebo
    • Hartford, Connecticut
      Hartford Hospital
    Jan 7, 2022

    Super-refractory Status Epilepticus After Cardiac Arrest

    Recruiting
    • Status Epilepticus
    • Cardiac Arrest
    • Ketamine
    • Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel
    • Brescia, BS, Italy
    • +6 more
    Mar 1, 2023

    Depressive Disorder, Treatment-Resistant Trial in London (Naltrexone, Placebo, Ketamine)

    Recruiting
    • Depressive Disorder, Treatment-Resistant
    • London, United Kingdom
      King's College London
    Sep 28, 2021

    Depression Trial in New Haven (Ketamine)

    Completed
    • Depression
    • New Haven, Connecticut
      Yale Depression Research Program
    Sep 7, 2021

    Cocaine Dependence, Healthy Trial in New Haven (N-acetyl cysteine, [18F]FDG PET scan, 1H MRS)

    Active, not recruiting
    • Cocaine Dependence
    • Healthy
    • N-acetyl cysteine
    • +3 more
    • New Haven, Connecticut
      Connecticut Mental Health Center
    May 20, 2022